Cetera Investment Advisers’s CapForce IBD 50 ETF FFTY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-27,283
Closed -$667K 2135
2022
Q3
$667K Sell
27,283
-3,625
-12% -$100K 0.01% 878
2022
Q2
$830K Sell
30,908
-1,000
-3% -$32.1K 0.01% 869
2022
Q1
$1.25M Sell
31,908
-2,444
-7% -$94.8K 0.02% 742
2021
Q4
$1.57M Sell
34,352
-370
-1% -$17.7K 0.02% 631
2021
Q3
$1.65M Sell
34,722
-1,600
-4% -$74.8K 0.03% 585
2021
Q2
$1.68M Sell
36,322
-1,986
-5% -$89.9K 0.03% 574
2021
Q1
$1.68M Sell
38,308
-8,508
-18% -$386K 0.03% 473
2020
Q4
$1.92M Buy
+46,816
New +$1.83M 0.04% 440
2016
Q2
Sell
-18,801
Closed -$395K 300
2016
Q1
$395K Sell
18,801
-2,419
-11% -$48.8K 0.17% 150
2015
Q4
$473K Buy
+21,220
New +$486K 0.22% 131

Other funds holding FFTY

Cetera Investment Advisers's FFTY Position: Q4 2022 in Review

Cetera Investment Advisers sold out of CapForce IBD 50 ETF (FFTY) in Q4 2022, closing a stake of 27,283 shares — an estimated $667K sold.

Cetera Investment Advisers first reported a position in FFTY in Q4 2015 and held it in 10 quarters. The position peaked at $1.92M in Q4 2020. 49 funds tracked by Wall St. Rank hold FFTY as of Q4 2022.

  • Cetera Investment Advisers reported no remaining CapForce IBD 50 ETF position as of Q4 2022 after selling out during the quarter.
  • Cetera Investment Advisers sold 27,283 CapForce IBD 50 ETF shares in Q4 2022, an estimated $667K.
  • Cetera Investment Advisers first reported a position in CapForce IBD 50 ETF in Q4 2015 and held it in 10 quarters.
  • Cetera Investment Advisers's CapForce IBD 50 ETF position peaked at $1.92M in Q4 2020.
  • 49 funds tracked by Wall St. Rank held CapForce IBD 50 ETF as of Q4 2022.

Based on Cetera Investment Advisers's 13F filing for Q4 2022, filed 14 Feb 2023.